This is a non-core endpoint: only basic statistics are computed.
Mesothelioma
C3_MESOTHELIOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
399 |
4. Check minimum number of eventsNone |
399 |
5. Include endpointsNone |
399 |
6. Filter based on genotype QC (FinnGen only) |
359 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C45-C49
- Name in latin
- Mesothelioma
Similar endpoints
↥List of similar endpoints to
Mesothelioma
based on the number of shared cases.
Similar with more cases:
- Mesothelioma, including Hilmo
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 359 | 71 | 288 |
| Unadjusted period prevalence (%) | 0.11 | 0.03 | 0.13 |
| Median age at first event (years) | 72.87 | 70.95 | 73.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 374
- Matched controls
- 3740
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
312.6
307.7
202
14
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
307.7
326
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
109.6
307.7
248
66
130
Kela drug reimbursment
Malignant tumour
+∞
301.4
247
*
Z51.5
ICD-10 Finland
Palliative care
34.5
243.7
181
99
A03FA01
ATC
metoclopramide; systemic, rectal
27.3
242.0
223
192
A04AA01
ATC
ondansetron; systemic, rectal
69.0
221.5
125
27
N02AA05
ATC
oxycodone; systemic
17.6
181.9
250
384
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
49.6
177.0
107
30
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
172.7
152
*
J94.8
ICD-10 Finland
Other specified pleural conditions
44.4
170.3
106
33
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
25.3
157.8
123
71
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
134.8
121
*
TGA30
NOMESCO Finland
Thoracocentesis
82.9
126.8
68
10
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
769.3
117.9
110
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
28.5
117.1
83
37
JN4BD
NOMESCO Finland
Extensive body CT
14.7
102.9
105
97
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
41.9
92.5
57
16
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
83.5
77
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
23.5
83.5
63
32
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.8
63.7
76
86
A04AA02
ATC
granisetron; systemic, transdermal
+∞
62.3
58
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.9
61.7
54
37
GD1AD
NOMESCO Finland
Thorax CT examination
9.1
59.8
83
114
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.9
58.3
111
216
GAC00
NOMESCO Finland
Biopsy of pleura
174.5
57.7
59
*
JN4AD
NOMESCO Finland
Body CT examination
8.0
57.0
89
140
L01CA04
ATC
vinorelbine; systemic
+∞
55.6
52
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.3
53.0
91
158
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
572.0
51.8
50
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
519.5
47.4
46
*
C45.9
ICD-10 Finland
Mesothelioma, unspecified
+∞
46.9
44
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
45.8
43
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
43.6
41
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
43.6
41
*
N02AA01
ATC
morphine; systemic, rectal
15.4
43.1
39
28
1BA04, ,
NOMESCO Finland
+∞
40.3
38
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
40.3
38
*
B03BA03
ATC
hydroxocobalamin; parenteral
6.3
40.3
78
151
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
58.0
39.6
46
9
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
39.3
37
*
ZX120
NOMESCO Finland
Intravenous
6.6
38.1
68
121
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
37.1
35
*
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
+∞
36.0
34
*
J94.9
ICD-10 Finland
Pleural condition, unspecified
57.3
35.2
41
8
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
7.6
33.1
50
74
R84
ICPC
Malignant neoplasm bronchus/lung
352.3
32.4
32
*
A06AH03
ATC
naloxegol; oral
76.8
31.5
35
5
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
120.3
31.2
33
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
30.6
29
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
29.2
260
1457
WZC00
NOMESCO Finland
Treatment plan or consultation
3.5
29.2
144
564
XX3DW
NOMESCO Finland
Time consuming IT work
7.4
29.2
45
68
J01MA14
ATC
moxifloxacin; systemic
4.8
28.6
74
183
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
+∞
28.5
27
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
28.5
27
*
WZC30
NOMESCO Finland
Teaching
4.1
27.0
89
264
WX600
NOMESCO Finland
Single shot through catheter
150.9
27.0
28
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
26.7
136
539
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.5
25.4
44
75
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
96.8
25.0
27
*
L03AA13
ATC
pegfilgrastim; parenteral
267.1
25.0
25
*
A79
ICPC
Malignancy NOS
+∞
24.2
23
*
TK800
NOMESCO Finland
Hemodialysis
9.2
24.0
30
35
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
244.3
22.9
23
*
GAA31
NOMESCO Finland
Thoracoscopy
244.3
22.9
23
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
127.9
22.9
24
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
21.8
22.1
32
16
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
22.1
21
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
21.8
88
297
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
233.1
21.8
22
*
J01MA12
ATC
levofloxacin; systemic
3.1
21.5
116
468
WW500
NOMESCO Finland
Blood transfusion
8.7
20.8
27
33
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
20.0
19
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.7
18.9
47
111
116
Kela drug reimbursment
Prostate cancer
+∞
18.9
18
*
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
16.7
17.8
28
18
R82
ICPC
Pleurisy/pleural effusion
188.6
17.7
18
*
R85
ICPC
Malignant neopl respiratory other
+∞
16.8
16
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
16.8
16
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
177.6
16.6
17
*
L03AA02
ATC
filgrastim; parenteral
177.6
16.6
17
*
A04AD12
ATC
aprepitant; systemic
+∞
15.7
15
*
C45
ICD-10 Finland
Mesothelioma
+∞
15.7
15
*
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
15.7
15
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
15.4
51
149
WW200, ,
SPAT
0.2
15.0
17
834
H02AB06
ATC
prednisolone; systemic
2.4
14.7
205
1271
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
14.6
108
504
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
55.5
13.9
16
*
WF002
NOMESCO Finland
Radical radiotherapy
55.5
13.9
16
*
GAC30
NOMESCO Finland
Artificial pneumothorax
+∞
13.6
13
*
C45.7
ICD-10 Finland
Mesothelioma of other sites
+∞
13.6
13
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
L02AE02
ATC
leuprorelin; implant, parenteral
145.1
13.5
14
*
N03AX16
ATC
[U] pregabalin
2.6
13.4
101
473
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
12.8
159
925
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
72.4
12.7
14
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
12.6
12
*
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
12.6
12
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
12.6
12
*
GAC43
NOMESCO Finland
Total decortication of pleura
134.3
12.5
13
*
B01AB10
ATC
tinzaparin; parenteral
3.4
12.2
48
157
JN4CD
NOMESCO Finland
Very extensive body CT
10.6
12.2
23
23
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
12.1
105
523
J86.9
ICD-10 Finland
Pyothorax without fistula
12.3
12.0
21
18
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
48.3
12.0
14
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
48.3
12.0
14
*
R06.0
ICD-10 Finland
Dyspnoea
2.2
11.8
145
834
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.5
11
*
Z2446
NOMESCO Finland
Social worker
3.8
11.5
36
101
ZX090
NOMESCO Finland
Other technic of radiotherapy
44.7
11.0
13
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
61.8
10.7
12
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.5
10
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
33.6
10.4
13
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
10.1
59
242
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
10.0
36
111
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
9.1
9.9
20
23
R4110
NOMESCO Finland
Physiotherapy
2.1
9.8
113
627
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.7
9.7
20
24
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.0
9.6
*
262
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.9
9.5
21
28
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
9.5
151
941
N06DX01
ATC
memantine; oral
0.1
9.5
*
333
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
102.5
9.5
10
*
Y77
ICPC
Malignant neoplasm prostate
102.5
9.5
10
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.9
9.4
21
45
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
9.4
9
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
9.4
9
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
9.4
9
*
R18
ICD-10 Finland
Ascites
7.3
9.2
21
30
Z2221
NOMESCO Finland
Medical doctor
2.1
9.1
103
564
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
9.4
9.1
18
20
J93.9
ICD-10 Finland
Pneumothorax, unspecified
20.6
8.5
12
6
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
20.6
8.5
12
6
GAC46
NOMESCO Finland
Partial decortication of pleura
92.1
8.4
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
8.4
138
863
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.4
8
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.4
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.4
8
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
WPA16, ,
SPAT
+∞
8.4
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
B01AB04
ATC
dalteparin; parenteral
3.9
8.2
24
64
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
34.2
8.1
10
*
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
6.3
8.0
20
33
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.6
7.8
19
30
P20
ICPC
Memory disturbance
0.3
7.7
19
602
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
18.8
7.6
11
6
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
18.8
7.6
11
6
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
81.6
7.4
8
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
81.6
7.4
8
*
OAB42, ,
SPAT
0.2
7.4
5
302
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
WPA43, ,
SPAT
+∞
7.3
7
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
+∞
7.3
7
*
N05CF01
ATC
zopiclone; oral
1.9
7.2
133
855
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
30.7
7.2
9
*
N06DA02
ATC
donepezil; oral
0.1
7.2
*
255
WW200
NOMESCO Finland
Immunization
4.5
7.0
17
39
R96
ICPC
Asthma
0.0
6.9
*
203
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
6.9
79
1303
J93.8
ICD-10 Finland
Other pneumothorax
14.1
6.9
11
8
C10AA05
ATC
atorvastatin; oral
0.5
6.9
99
1518
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
6.9
84
470
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.9
6.8
18
32
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
6.8
60
295
R52.0
ICD-10 Finland
Acute pain
4.4
6.8
17
40
B01AB05
ATC
enoxaparin; parenteral
1.9
6.8
118
742
WZC30, ,
SPAT
0.1
6.7
*
219
C10AX09
ATC
ezetimibe; oral
0.3
6.7
17
533
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.6
162
1129
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
6.6
60
300
ZXE00
NOMESCO Finland
One hour or less
1.8
6.5
138
922
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
7.6
6.5
14
19
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
71.0
6.4
7
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.4
6.4
23
71
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
6.3
22
588
JAL30
NOMESCO Finland
Omentectomy
18.4
6.3
9
5
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
GAC20
NOMESCO Finland
Excision or destruction of lesion of pleura
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
Z57.2
ICD-10 Finland
Occupational exposure to dust
7.9
6.2
13
17
C10AA07
ATC
rosuvastatin; oral
0.5
6.2
49
923
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
173
63
50.23
271.11
2.0
1.3
40.57
27.25
g/l
10.14
165
56
154
55
46.90
241.22
2.1
1.3
1651.34
2027.03
e6/l
0.29
123
38
146
47
50.32
235.48
2.1
1.3
40495.45
193894.73
e6/l
0.55
103
26
120
80
21.61
143.26
2.2
1.4
—
—
—
0
0
141
136
16.04
136.74
2.5
3.2
—
—
—
0
0
136
159
12.87
114.79
2.2
1.4
2.12
2.80
ug/l
2.82
108
115
72
89
9.78
56.22
1.5
1.5
—
—
—
0
0
157
487
4.83
47.68
5.5
2.4
0.78
0.83
mmol/l
8.16
148
454
253
1548
2.96
21.54
17.6
5.5
5.14
4.60
e9/l
1.36
224
1316
30
41
7.87
21.08
1.9
1.6
87.70
38.17
u/ml
0.41
30
41
29
42
7.40
19.37
7.9
6.9
10.87
12.69
mg/l
1.40
29
42
38
76
5.45
18.51
1.2
1.8
—
—
—
0
0
26
16
17.36
16.80
2.0
1.1
43.62
24.41
ng/l
0.37
26
16
221
1372
2.49
16.45
7.8
3.9
30.11
34.90
g/l
20.27
215
1280
25
37
7.17
16.34
1.1
1.0
—
—
—
0
0
194
2697
0.42
15.28
5.8
8.0
40.83
40.94
mmol/mol
0.06
168
2476
42
1162
0.28
14.84
1.6
1.9
1.37
1.24
mmol/l
0.62
37
937
221
1437
2.31
13.92
7.9
5.9
1.20
1.20
mmol/l
0.07
212
1300
171
999
2.31
13.90
6.8
2.1
2.34
2.35
mmol/l
0.09
158
853
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
121
3.89
13.69
2.9
2.4
0.30
0.40
iu/ml
0.83
22
62
124
642
2.39
13.21
6.2
2.1
2.53
2.44
mmol/l
11.84
112
558
243
1672
2.29
12.99
10.7
21.2
1.13
1.42
inr
20.98
206
1402
235
1610
2.24
12.48
9.6
6.4
1.20
1.20
mmol/l
0.01
210
1367
61
233
2.93
11.94
4.1
3.8
2.76
2.11
mmol/l
0.76
56
171
204
2695
0.47
11.65
4.0
5.6
1.38
1.37
mmol/l
0.15
167
2435
208
2720
0.47
11.30
3.9
5.7
4.28
4.20
mmol/l
0.54
169
2480
216
2783
0.47
11.13
4.1
6.7
2.50
2.40
mmol/l
1.01
174
2525
127
717
2.17
10.64
3.6
2.2
—
—
—
0
0
41
144
3.07
9.24
5.1
4.4
25.90
24.88
mmol/l
1.15
41
133
20
45
4.64
8.47
1.4
1.4
—
—
—
0
0
71
1271
0.46
8.29
3.0
3.5
8.04
7.72
mmol/l
0.25
57
1061
203
2580
0.53
8.02
3.5
4.8
1.23
1.26
mmol/l
0.18
161
2306
13
10
13.41
7.93
1.6
1.5
—
—
—
0
0
34
117
3.10
7.93
1.5
1.9
31.00
38.32
u/l
1.42
29
96
75
1301
0.47
7.92
4.0
4.3
4.21
9.28
mg/mmol
1.99
41
853
75
1277
0.48
7.36
2.1
2.3
79.67
78.39
nmol/l
0.12
63
1106
207
2590
0.55
7.27
6.5
4.7
2.23
2.05
mu/l
0.51
187
2318
17
27
6.54
7.02
1.3
1.3
—
—
—
0
0
104
630
1.90
6.72
2.0
1.9
—
—
—
0
0
132
864
1.82
6.67
4.6
2.5
28.98
37.61
u/l
2.18
126
815
107
1577
0.55
6.31
2.0
2.3
91.39
92.79
pmol/l
0.11
65
866
137
923
1.76
6.19
4.5
2.2
53.53
61.80
u/l
0.84
130
848
232
2769
0.57
6.07
5.2
6.0
6.28
6.19
mmol/l
0.31
200
2486
8
5
16.29
5.43
1.6
1.0
2.05
7.62
nmol/l
—
8
5
5
0
+∞
5.22
5.4
0.0
41.20
—
u/l
—
5
0
96
612
1.76
5.11
1.8
1.6
1.89
1.69
mg/l
0.27
76
495
70
1112
0.54
5.02
1.7
1.8
23.51
18.93
nmol/l
1.76
65
921
15
41
3.77
4.97
2.3
4.1
—
—
—
0
0
21
73
2.99
4.84
1.3
1.3
—
—
—
0
0
37
711
0.47
4.75
3.4
4.3
1.02
1.02
kg/l
0.30
29
452
264
2214
1.65
4.64
17.3
5.5
88.89
79.15
u/l
3.19
259
2047
38
182
2.21
4.61
1.7
1.6
—
—
—
0
0
43
217
2.11
4.58
1.6
1.5
—
—
—
0
0
131
932
1.62
4.56
2.5
3.0
0.93
0.40
e6/l
1.08
103
682
115
1568
0.62
4.45
3.2
4.0
0.00
0.01
estimate
0.50
32
317
22
84
2.72
4.31
5.4
3.7
1.75
1.63
index
0.04
16
51
30
134
2.35
4.28
2.3
1.7
—
—
—
0
0
173
1330
1.56
4.27
4.0
2.5
—
—
estimate
—
0
0
12
25
4.92
4.22
1.0
1.4
—
—
—
0
0
116
1557
0.63
4.07
3.2
3.9
47.06
0.00
estimate
0.49
34
342
74
468
1.72
3.99
8.2
6.8
1.88
1.01
mmol/l
1.31
65
389
168
2076
0.65
3.96
5.6
3.5
15.06
15.07
pmol/l
0.01
154
1846
230
1903
1.54
3.95
8.6
4.9
6.78
6.96
mmol/l
0.96
225
1814
45
245
1.95
3.91
1.9
1.6
—
—
—
0
0
115
1533
0.64
3.84
3.2
3.9
0.00
0.00
estimate
-0.00
34
334
27
124
2.27
3.64
2.3
1.5
—
—
—
0
0
13
35
3.81
3.63
1.5
1.4
—
—
—
0
0
82
1168
0.62
3.62
3.3
4.1
0.00
0.00
estimate
-0.00
32
277
13
36
3.70
3.53
1.5
1.2
—
—
—
0
0
19
75
2.62
3.52
1.4
1.3
—
—
—
0
0
154
1201
1.48
3.33
2.6
3.1
—
—
—
0
0
14
49
2.93
3.22
1.4
1.3
—
—
—
0
0
10
26
3.92
3.00
1.6
1.3
—
—
—
0
0
118
1511
0.68
2.99
3.9
4.4
22.00
24.71
%
1.37
62
786
21
95
2.28
2.96
1.6
2.4
118.50
130.81
g/l
0.79
14
76
8
17
4.78
2.93
7.4
2.7
0.38
1.06
index
—
8
17
17
70
2.50
2.92
1.4
1.2
—
—
—
0
0
72
490
1.58
2.90
1.8
1.8
—
—
—
0
0
12
38
3.23
2.87
1.7
1.4
89.02
90.15
%
0.32
12
38
74
508
1.57
2.87
9.3
6.6
103.53
104.60
mmol/l
1.12
74
508
10
28
3.64
2.80
1.1
1.4
—
—
—
0
0
67
455
1.58
2.72
5.3
5.2
1.06
1.02
mmol/l
0.38
62
413
154
1860
0.71
2.72
5.0
4.7
2.54
2.17
ug/l
0.71
128
1663
9
24
3.82
2.69
1.1
1.5
—
—
—
0
0
15
61
2.52
2.65
1.4
1.2
—
—
—
0
0
5
7
7.22
2.55
1.6
1.0
74.80
86.29
nmol/l
—
5
7
136
1080
1.41
2.52
2.6
3.1
43.34
120.93
e6/l
0.63
107
823
10
249
0.39
2.45
8.8
2.2
73.80
56.07
ml/min/173m2
—
5
98
56
805
0.64
2.43
1.7
1.8
516.33
407.52
pmol/l
1.31
46
652
65
457
1.51
2.26
1.8
1.8
—
—
—
0
0
95
720
1.43
2.26
5.6
4.3
68.21
444.88
ng/l
3.88
81
636
14
60
2.39
2.24
1.4
1.2
—
—
—
0
0
17
81
2.15
2.16
1.5
1.6
0.02
0.12
iu/ml
—
7
18
16
76
2.15
2.05
1.7
1.3
—
—
—
0
0
16
76
2.15
2.05
1.7
1.3
—
—
—
0
0
7
21
3.38
1.97
1.7
1.2
—
—
—
0
0
6
16
3.79
1.94
1.7
1.3
—
—
—
0
0
6
17
3.57
1.84
1.7
1.3
—
—
—
0
0
38
250
1.58
1.79
1.2
1.5
—
—
—
0
0
6
18
3.37
1.75
1.5
4.7
—
—
—
0
0
15
278
0.52
1.72
2.7
2.4
0.29
0.37
e6/l
0.23
15
260
71
537
1.40
1.70
2.5
3.0
1.65
1.10
e6/l
0.39
37
273
277
2963
0.75
1.62
52.8
25.4
304.86
228.91
e9/l
27.30
267
2888
277
2963
0.75
1.62
53.0
25.5
122.79
135.20
g/l
27.13
272
2912
277
2963
0.75
1.62
53.8
26.0
37.76
40.14
%
11.52
272
2913
277
2963
0.75
1.62
52.7
25.4
4.25
4.45
e12/l
8.19
267
2867
277
2962
0.75
1.61
52.6
25.3
89.94
92.07
fl
10.88
272
2911
17
93
1.87
1.54
1.1
1.3
—
—
—
0
0
274
2929
0.76
1.53
39.9
22.1
4.03
4.04
mmol/l
0.08
268
2861
274
2927
0.76
1.50
39.9
22.0
138.18
139.78
mmol/l
13.29
268
2864
277
2953
0.76
1.48
44.7
23.1
83.76
89.37
umol/l
1.66
272
2909
72
907
0.74
1.45
3.3
3.9
0.00
0.00
estimate
-0.00
31
301
270
2882
0.77
1.40
21.5
10.8
23.11
25.00
u/l
1.50
263
2757
6
23
2.63
1.37
1.3
1.3
—
—
—
0
0
0
38
0.00
1.35
0.0
1.0
—
48.36
—
0
25
0
38
0.00
1.35
0.0
1.0
—
611.38
—
0
26
9
42
2.17
1.34
3.8
2.8
0.83
0.84
mmol/l
—
9
42
6
24
2.52
1.31
1.3
1.3
—
—
—
0
0
6
24
2.52
1.31
1.3
1.3
—
—
—
0
0
14
77
1.85
1.27
1.1
1.2
—
—
—
0
0
14
78
1.83
1.22
1.1
1.2
—
—
—
0
0
6
26
2.33
1.19
1.5
1.2
—
—
—
0
0
6
26
2.33
1.19
1.5
1.2
—
—
—
0
0
6
26
2.33
1.19
1.5
1.2
—
—
—
0
0
248
2655
0.80
1.18
35.0
16.7
75.92
71.67
ml/min/173m2
3.11
236
2484
64
791
0.77
1.11
3.3
3.5
0.00
0.00
estimate
0.50
30
257
5
22
2.29
1.03
1.2
1.2
82.60
36.18
u/l
—
5
17
31
421
0.71
1.02
7.3
7.1
—
—
—
0
0
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
39
503
0.75
0.93
1.3
1.2
0.96
1.67
u/ml
—
5
137
5
105
0.47
0.90
1.0
2.2
2.98
3.33
ratio
—
5
92
15
95
1.60
0.88
1.1
1.2
—
—
—
0
0
10
57
1.78
0.84
1.4
1.3
—
—
—
0
0
111
1253
0.84
0.82
2.6
3.0
461.53
156.08
ug/l
2.87
105
1144
6
33
1.83
0.79
1.2
1.4
—
—
—
0
0
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
16
231
0.68
0.76
5.8
3.8
52.17
47.58
%
0.25
16
224
68
575
1.22
0.75
2.4
2.9
1.95
1.00
e6/l
0.71
34
313
56
464
1.24
0.75
1.4
1.3
31.00
36.34
iu/ml
0.17
11
135
205
2185
0.86
0.71
45.8
20.6
14.63
13.80
%
12.69
205
2149
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
74
849
0.84
0.66
2.7
2.7
346.85
371.97
umol/l
1.07
62
727
0
22
0.00
0.59
0.0
1.5
—
88.69
—
0
22
51
431
1.21
0.59
1.3
1.3
24.50
12.46
u/ml
0.21
11
146
16
207
0.76
0.44
3.5
3.0
25.76
25.05
mmol/l
0.47
16
201
40
343
1.19
0.42
4.7
3.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
20
248
0.80
0.40
1.1
1.3
—
—
—
0
0
138
1294
1.11
0.39
3.4
3.4
1089.10
1827.40
ng/l
2.99
129
1140
30
354
0.83
0.39
3.3
2.9
4.61
4.44
kpa
0.19
30
342
63
699
0.88
0.38
1.6
1.8
1061.93
1155.28
nmol/l
0.32
40
533
132
1239
1.10
0.37
2.4
2.3
—
—
—
0
0
35
404
0.85
0.36
4.4
5.6
34.50
32.21
%
0.47
24
268
210
2181
0.92
0.35
4.5
4.3
28.30
13.06
mm/h
10.00
204
1988
13
101
1.30
0.32
1.3
1.2
37.56
89.23
u/ml
—
5
39
18
216
0.82
0.29
2.4
2.7
1.18
1.08
%
0.36
18
216
8
66
1.22
0.27
1.6
1.9
—
—
—
0
0
18
211
0.85
0.23
2.4
2.6
0.57
0.62
%
0.26
18
211
0
11
0.00
0.21
0.0
7.1
—
5.95
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
1913.80
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.04
—
0
8
6
53
1.13
0.19
3.3
2.8
1.20
1.18
mmol/l
—
6
53
8
69
1.16
0.16
1.3
1.3
—
—
—
0
0
16
182
0.87
0.15
4.7
4.0
1.67
1.66
%
0.03
16
177
9
81
1.11
0.15
1.0
1.0
—
—
—
0
0
100
1038
0.95
0.14
3.3
3.2
0.84
0.79
ug/l
0.26
76
751
94
910
1.04
0.11
2.0
2.3
3.45
2.81
mg/l
1.44
84
772
6
56
1.07
0.08
3.3
2.7
105.00
104.84
mmol/l
—
6
56
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
44
422
1.05
0.07
3.0
3.4
6.11
5.83
kpa
0.63
44
410
8
78
1.03
0.07
1.1
1.2
—
—
—
0
0
10
111
0.90
0.06
1.2
1.4
—
—
—
0
0
138
1399
0.98
0.05
5.1
4.4
37.85
77.71
ng/l
0.91
122
1109
164
1649
0.99
0.01
5.8
3.1
61.80
54.36
u/l
0.42
153
1513
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
1.43
—
0
7
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
0.20
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
9.21
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
1.0
1.1
18.84
23.28
u/l
—
5
53
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
-0.00
0.0
3.7
—
176.17
—
0
6
0
5
0.00
-0.00
0.0
2.8
—
14.14
—
0
5
8
82
0.98
-0.00
1.0
1.1
—
2.66
—
0
10
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
-0.00
0.0
1.5
—
75.50
—
0
6
0
8
0.00
-0.00
0.0
1.1
—
1.15
—
0
8
9
99
0.91
-0.00
1.0
1.2
—
—
—
0
0
8
88
0.91
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
10.2
—
4.60
—
0
5
0
9
0.00
-0.00
0.0
3.8
—
10.12
—
0
9
7
76
0.92
-0.00
1.6
1.7
—
—
—
0
0
276
2760
1.00
-0.00
41.8
16.8
54.75
28.33
mg/l
16.14
267
2288
0
9
0.00
-0.00
0.0
3.8
—
5.36
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.3
—
11.22
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MESOTHELIOMA – Mesothelioma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).